These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 30853322)

  • 1. What to do with repeated measurements of a continuous response variable.
    Nordgren R
    J Mol Cell Cardiol; 2019 Aug; 133():220-222. PubMed ID: 30853322
    [No Abstract]   [Full Text] [Related]  

  • 2. Preclinical research: Design animal studies better.
    Macleod MR
    Nature; 2014 Jun; 510(7503):35. PubMed ID: 24899295
    [No Abstract]   [Full Text] [Related]  

  • 3. Animal models: Mouse already being charted gene by gene.
    Brown S
    Nature; 2014 Apr; 508(7496):319. PubMed ID: 24740057
    [No Abstract]   [Full Text] [Related]  

  • 4. [Carcinogenicity studies in experimental animals. I. Design and performance].
    Feron VJ; de Vrijer F; van der Heijden CA
    Ned Tijdschr Geneeskd; 1986 Jun; 130(23):1049-51. PubMed ID: 3724897
    [No Abstract]   [Full Text] [Related]  

  • 5. Preclinical research: Make mouse studies work.
    Perrin S
    Nature; 2014 Mar; 507(7493):423-5. PubMed ID: 24678540
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preclinical research. Seal of approval translational medicine].
    Hermann S; Pichler B; Kotzerke J
    Nuklearmedizin; 2013 Dec; 52(6):N53-4. PubMed ID: 24337015
    [No Abstract]   [Full Text] [Related]  

  • 7. Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection.
    Bøtker HE; Hausenloy D; Andreadou I; Antonucci S; Boengler K; Davidson SM; Deshwal S; Devaux Y; Di Lisa F; Di Sante M; Efentakis P; Femminò S; García-Dorado D; Giricz Z; Ibanez B; Iliodromitis E; Kaludercic N; Kleinbongard P; Neuhäuser M; Ovize M; Pagliaro P; Rahbek-Schmidt M; Ruiz-Meana M; Schlüter KD; Schulz R; Skyschally A; Wilder C; Yellon DM; Ferdinandy P; Heusch G
    Basic Res Cardiol; 2018 Aug; 113(5):39. PubMed ID: 30120595
    [No Abstract]   [Full Text] [Related]  

  • 8. Biostatistics in nonclinical and preclinical drug development.
    Hothorn LA
    Biom J; 2005 Jun; 47(3):282-5. PubMed ID: 16053252
    [No Abstract]   [Full Text] [Related]  

  • 9. Consider drug efficacy before first-in-human trials.
    Kimmelman J; Federico C
    Nature; 2017 Jan; 542(7639):25-27. PubMed ID: 28150789
    [No Abstract]   [Full Text] [Related]  

  • 10. The Open Field Test: reinventing the wheel.
    Stanford SC
    J Psychopharmacol; 2007 Mar; 21(2):134-5. PubMed ID: 17329288
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiepileptic drug development: II. Anticonvulsant drug screening.
    Krall RL; Penry JK; White BG; Kupferberg HJ; Swinyard EA
    Epilepsia; 1978 Aug; 19(4):409-28. PubMed ID: 699894
    [No Abstract]   [Full Text] [Related]  

  • 12. Statistical considerations for preclinical studies.
    Aban IB; George B
    Exp Neurol; 2015 Aug; 270():82-7. PubMed ID: 25725352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing prospective clinical pharmacogenomic (PG) trials: meeting report on drug development strategies to enhance therapeutic decision making.
    Trepicchio WL; Essayan D; Hall ST; Schechter G; Tezak Z; Wang SJ; Weinreich D; Simon R
    Pharmacogenomics J; 2006; 6(2):89-94. PubMed ID: 16402088
    [No Abstract]   [Full Text] [Related]  

  • 14. The debate on animal ADME studies in drug development: an update.
    Pellegatti M
    Expert Opin Drug Metab Toxicol; 2014 Dec; 10(12):1615-20. PubMed ID: 25373428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental design and statistical methods for improved hit detection in high-throughput screening.
    Malo N; Hanley JA; Carlile G; Liu J; Pelletier J; Thomas D; Nadon R
    J Biomol Screen; 2010 Sep; 15(8):990-1000. PubMed ID: 20817887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An FDA oncology view of juvenile animal studies in support of initial pediatric trials for anticancer drugs.
    Leighton JK; Saber H; Reaman G; Pazdur R
    Regul Toxicol Pharmacol; 2016 Aug; 79():142-143. PubMed ID: 26952647
    [No Abstract]   [Full Text] [Related]  

  • 17. Criteria for valid preclinical trials using animal stroke models.
    Rosenblum WI
    Stroke; 1993 Oct; 24(10):1601-2. PubMed ID: 8378968
    [No Abstract]   [Full Text] [Related]  

  • 18. Can you trust your animal study data?
    Peers IS; South MC; Ceuppens PR; Bright JD; Pilling E
    Nat Rev Drug Discov; 2014 Jul; 13(7):560. PubMed ID: 24903777
    [No Abstract]   [Full Text] [Related]  

  • 19. [The current requirements for the preclinical study of the safety of new drugs].
    Arzamastsev EV; Liubimov BI
    Eksp Klin Farmakol; 1995; 58(3):7-12. PubMed ID: 7663306
    [No Abstract]   [Full Text] [Related]  

  • 20. A clinical scientist's view of preclinical drug testing requirements.
    Dayan AD
    Hum Exp Toxicol; 1991 Nov; 10(6):395-7. PubMed ID: 1687848
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.